Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-12
Closed -$24 2719
2025
Q2
$24 Buy
+12
New +$22 ﹤0.01% 2213

Essential Partners's HLVX Position: Q3 2025 in Review

Essential Partners sold out of HilleVax (HLVX) in Q3 2025, closing a stake of 12 shares — an estimated $24 sold.

Essential Partners first reported a position in HLVX in Q2 2025 and held it in 1 quarter. The position peaked at $24 in Q2 2025. 1 fund tracked by Wall St. Rank holds HLVX as of Q3 2025.

  • Essential Partners reported no remaining HilleVax position as of Q3 2025 after selling out during the quarter.
  • Essential Partners sold 12 HilleVax shares in Q3 2025, an estimated $24.
  • Essential Partners first reported a position in HilleVax in Q2 2025 and held it in 1 quarter.
  • Essential Partners's HilleVax position peaked at $24 in Q2 2025.
  • 1 fund tracked by Wall St. Rank held HilleVax as of Q3 2025.

Based on Essential Partners's 13F filing for Q3 2025, filed 21 May 2026.